3
Announcements
Trials
Browse
Landscape
Status
Completed
10
Recruiting
2
Active not recruiting
2
Withdrawn
1
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Unresectable Hepatocellular Carcinoma
1
Stomatitis
1
Respiratory Aspiration
1
Recurrence
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Periodontitis
1
Pain
1
Ovariancancer
1
Ovarian Neoplasms
1
Non Small Cell Lung Caner
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Myasthenia Gravis
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Calculi
1
Immune Checkpoint Inhibitor-Induced Dermatitis
1
Head and Neck Neoplasms
1
Febrile Neutropenia
1
Fatigue
1
Dupuytren Contracture
1
Depression
1
Interventions
Cyclophosphamide
10
Rituximab
9
polatuzumab vedotin
6
Prednisone
6
Doxorubicin
6
Vincristine
5
zanubrutinib
4
glofitamab
4
Prednisolone
4
Lenalidomide
4
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
3
Lisaftoclax
3
tafasitamab
2
obinutuzumab
2
fludarabine
2
Radiotherapy
2
R-CHOP protocol
2
Observation
2
venetoclax
1
sintilimab
1
resiniferatoxin
1
penpulimab
1
pegfilgrastim
1
orelabrutinib
1
loncastuximab tesirine
1
duvelisib
1
acalabrutinib
1
Vancomycin
1
Therapeutics
1
Tamoxifen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Lymphoma, Large B-Cell, Diffuse
×
Therapeutics
×
Clear all
NCT07463781
2026-03-13
NEURO_CAR-T
Fondazione Italiana Linfomi - ETS
Not yet recruiting
100 enrolled